Table 3: Clinical and pathological data.

Grade
 High12/12 (100%)
Concomitant CIS2/12 (16%)
cTNM
 T3a4/12 (33%)
 T3b6/12 (50%)
 T42/12 (16%)
 N06/12 (50%)
 N12/12 (16%)
 N22/12 (16%)
 N32/12 (16%)
 M08/12 (67%)
 M14/12 (33%)
pTNM
 T2b2/12 (16%)
 T3a4/12 (33%)
 T46/12 (50%)
 N04/12 (33%)
 N14/12 (33%)
 N22/12 (16%)
 N32/12 (16%)
 M08/12 (67%)
 Mx4/12 (33%)
Mean lymph node removed17 (12–21)
Urinary diversion
 UCS4/12 (33%)
 IC4/12 (33%)
 Orthotopic ileal neobladder2/12 (16%)
Overall PSM4/12 (33%)
Positive STSM1/12 (8%)
Concomitant prostate cancer4/12

UCS: ureterocutaneostomy; IC: ileal conduit; PSM: positive surgical margins; STSM: soft tissue surgical margin.